Warning letter
Marlen Manufacturing & Development Co. [ARCHIVED]: warning letter of Aug 28, 2009
FDA warning letter 74844 · Cincinnati District Office
Key facts
| Reference number | 74844 |
|---|---|
| Company | Marlen Manufacturing & Development Co. [ARCHIVED] |
| Subject | CGMP/QSR/Adulterated/Misbranded |
| Issue date | Aug 28, 2009 |
| Posted date | Aug 28, 2009 |
| Issuing office | Cincinnati District Office |
| Product type | Devices |
| CFR sections cited | 803.17, 803, 820 |
| Inspection city | Bedford |
| Inspection ZIP | 44146 |
| Inspection start date | Jun 25, 2009 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: